Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overviewAll 13F holders of KALVFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of KALV by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−45,444−100.0%Sold outHolders
Q3 202545,444$553.5K<0.1%−127,765−73.8%ReducedHolders
Q2 2025173,209$1.96M<0.1%−472,784−73.2%ReducedHolders
Q1 2025645,993$7.46M<0.1%−50,044−7.2%ReducedHolders
Q4 2024696,037$5.90M<0.1%+89,001+14.7%AddedHolders
Q3 2024607,036$7.03M<0.1%+72,057+13.5%AddedHolders
Q2 2024534,979$6.30M<0.1%−44,680−7.7%ReducedHolders
Q1 2024579,659$6.87M<0.1%−137,305−19.2%ReducedHolders
Q4 2023716,964$8.78M<0.1%+134,059+23.0%AddedHolders
Q3 2023582,905$5.61M<0.1%+162,369+38.6%AddedHolders
Q2 2023420,536$3.78M<0.1%+184,269+78.0%AddedHolders
Q1 2023236,267$1.86M<0.1%−27,600−10.5%ReducedHolders
Q4 2022263,867$1.78M<0.1%−72,251−21.5%ReducedHolders
Q3 2022336,118$4.88M<0.1%+71,640+27.1%AddedHolders
Q2 2022264,478$2.60M<0.1%+188,926+250.1%AddedHolders
Q1 202275,552$1.11M<0.1%−92,779−55.1%ReducedHolders
Q4 2021168,331$2.23M<0.1%−1,877−1.1%ReducedHolders
Q3 2021170,208$2.97M<0.1%00.0%UnchangedHolders
Q2 2021170,208$4.08M<0.1%−58,417−25.6%ReducedHolders
Q1 2021228,625$5.87M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.